Clinical predictors of response to anakinra in patients with heart failure-Reference-Cited by-同舟云学术

Clinical predictors of response to anakinra in patients with heart failure

Published:2014-05 Issue:3 Volume:173 Page:537-539
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Canada Justin M.,Van Tassell Benjamin W.,Christopher Sanah,Oddi Claudia,Abouzaki Nayef A.,Gambill Michael L.,Mueller George,Melchior Ryan,Shah Keyur B.,Dinarello Charles A.,Abbate Antonio,Arena Ross

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Inflammation in chronic heart failure;Parish;Ann Pharmacother,2008

2. Targeting interleukin-1 in heart disease;Van Tassell;Circulation,2013

3. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure;Van Tassell;PLoS One,2012

4. Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure with preserved ejection fraction (from the D-HART pilot study);Van Tassell;Am J Cardiol,2014

5. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment;Borlaug;Eur Heart J,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist);Rheumatology Science and Practice;2022-07-01

2. Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications;Current Reviews in Clinical and Experimental Pharmacology;2021-09-22

3. Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure;Journal of Cardiovascular Pharmacology;2020-10-24

4. Cardiogenic Pulmonary Edema;The American Journal of the Medical Sciences;2019-12

5. Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein;The American Journal of Cardiology;2018-10